Orange Man, Brian McKee, delivers care packages to individuals who are isolating, to celebrate the 12th of July as traditional large-scale parades were cancelled this year due to the pandemic, in east Belfast, Monday, July 13, 2020. The Twelfth is being celebrated on 13 July as 12 July this year fell on a Sunday, to mark the anniversary of the victory of Protestant William of Orange over Catholic King James II at the Battle of the Boyne in July 1690. (Niall Carson/PA via AP)

Strong demand for virus testing services; snacking surges

July 13, 2020 - 1:28 pm

The outbreak of the coronavirus has dealt a shock to the global economy with unprecedented speed. Following are developments Monday related to the national and global response, the work place and the spread of the virus.

________________________

FRONT LINE VIRUS COMPANIES:

— Two vaccine candidates from Pfizer and BioNTech being developed to help protect against the virus that causes COVID-19 have received fast track designation from the U.S. Food and Drug Administration. The designation was granted based on preliminary data from early-state studies that are currently ongoing in the U.S. and Germany as well as animal immunogenicity studies. The vaccine candidates are not currently approved for distribution anywhere in the world.

The companies may begin later-stage trials, which would put the treatments closer to launch, as soon as this month, subject to regulatory approval. They anticipate enrolling up to 30,000 subjects. If the ongoing studies are successful, and the vaccine candidate receives regulatory approval, Pfizer and BioNTech currently expect to make up to 100 million doses by the end of the year and potentially more than 1.2 billion doses by the end of 2021.

— Quest Diagnostics is seeing growing demand for its COVID-19 testing services, though at a cost. The company said Monday that second-quarter testing volumes in its base business (excluding COVID-19 molecular and antibody testing) declined approximately 34% from a year ago, according to preliminary results.

Quest received $65 million in the second quarter from the initial tranche of funds that were appropriated to healthcare providers under the Coronavirus Aid, Relief, and Economic Security Act.

— PerkinElmer anticipates its second-quarter revenue will climb approximately 12%. The company said Monday that the increase was driven by better-than-expected demand for its full-suite of solutions aimed at helping support customers’ COVID-19 testing needs around the world.

PerkinElmer experienced strong demand for its RT-PCR and serology tests, RNA extraction systems and kits, and automated liquid handling instrumentation. In total, COVID-19 related solutions contributed about $190 million of revenue in the second quarter.

SNACK ATTACK: The munchies are real in quarantine, with PepsiCo reporting its snack sales rose in the second quarter while beverage sales declined.

Sales for the Frito Lay division climbed 7% in the period, while Quaker Foods revenue increased 23%. The North American beverage unit experienced a 7% decline in revenue.

RETAIL PAIN: Another retailer, the owner of the New York & Co. chain, is filing for bankruptcy protection.

RTW Retailwinds Inc. expects to close a significant number, if not all, of its stores. In the near term, it will continue to reopen stores under Chapter 11 bankruptcy protection.

The company has 378 retail and outlet locations in 32 states. In addition to New York & Co., it owns Fashion to Figure, and Happy x Nature.

RTW is evaluating all options including the potential sale of its online business and related intellectual property.

Brooks Brothers, J.C. Penney, J. Crew. and Sur la Table are among a dozen or so retailers that have sought bankruptcy protection after the pandemic forced stores closures nationwide.

TRAVEL: JetBlue Airways will continue to block middle seats through Sept. 8, long enough to cover Labor Day weekend and extending a policy that was due to end July 31. JetBlue, Delta and Southwest say they are blocking some seats, while United and American do not. A management and statistics professor at MIT estimates that leaving middle seats empty on planes reduces passengers’ chance of coronavirus infection by about half, to one in 4,300. The paper has not been peer-reviewed.

GOVERNMENTS & CENTRAL BANKS:

— The Czech Republic is reimposing restrictions for travel to Serbia and Montenegro after a spike of new coronavirus cases in the Balkan countries.

Starting Monday, the Czechs moved Serbia and Montenegro from an EU green list of safe countries to a red list of high risk countries. The move means that anyone coming to the Czech Republic from Serbia and Montenegro has to present a negative COVID-19 test or get quarantined.

The Czech Health Ministry says the two countries now have more than 50 positive COVID-19 cases per 100,000 people.

The citizens of Serbia and Montenegro are allowed to enter the Czech Republic only for several specific reasons, such as to work or visit relatives.

— Germany’s health minister says his country is willing to help other governments develop their own coronavirus tracing app, but stopped short of naming specific countries that have sought assistance from Berlin.

Jens Spahn told reporters in Berlin on Monday that the German app’s code is open source, meaning others can see how it works, and “of course there are enquiries from various countries.”

The German Corona-Warn-App has been downloaded more than 15.5 million times since its launch last month. Officials say that so far about 500 people in Germany who tested positive for the new coronavirus have received the code required to warn others who might have been exposed to them.

The app uses Bluetooth signals to register which other smartphone are nearby for at least 15 minutes. Strict privacy guards mean the German government doesn’t know how many warnings have been issued or to whom.

MARKETS: Stocks climbed worldwide Monday, as CEOs across the country prepare to tell their investors how much money they made, or lost, in the spring as the pandemic pounded the economy.

AP Editorial Categories: 
Comments ()